New Key Statistics Module, Z-Score and F-Score
BUE:GSK Key Ratios
Market Cap ARS M | 77,758,303.46 |
Enterprise Value ARS M | 92,802,326.68 |
P/E(ttm) | 17.11 |
PE Ratio without NRI | 15.48 |
Forward PE Ratio | 13.97 |
Price/Book | 5.11 |
Price/Sales | 2.43 |
Price/Free Cash Flow | 13.87 |
Price/Owner Earnings | 12.63 |
Payout Ratio % | 0.55 |
Revenue (TTM) ARS M | 17,265,373.00 |
EPS (TTM) ARS | 280.59 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -6.50 |
EV-to-EBIT | 13.61 |
EV-to-EBITDA | 10.04 |
PEG | 15.48 |
Shares Outstanding M | 8,156.05 |
Net Margin (%) | 14.59 |
Operating Margin % | 21.97 |
Pre-tax Margin (%) | 17.93 |
Quick Ratio | 0.58 |
Current Ratio | 0.87 |
ROA % (ttm) | 7.56 |
ROE % (ttm) | 34.58 |
ROIC % (ttm) | 12.07 |
Dividend Yield % | 1.78 |
Altman Z-Score | 1.95 |
BUE:GSK Number of Guru Trades
BUE:GSK Volume of Guru Trades
Gurus Latest Trades with BUE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BUE:GSK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data